EDNRB and ovarian carcinoma: ET-1/ETAR was overexpressed in the primary or metastatic ovarian cancer, as well as among ovarian cancer patient with ascites.9-11 Under physiological condition, ETBR plays as the counter-act for ET-1/ETAR mechanism by promoting ET-1 clearance, mediating apoptosis and inhibiting cell growth.